Risk factors in CHD

Saturday, 13 April 2002

Organizers

 P. Selvais (Hornu and Brussels, Belgium)
M. Hermans (Brussels, Belgium)
M. Rousseau (Brussels, Belgium)

Metabolic and neurohumoral parameters as risk factors in heart diseases

Session I

  

Abstract no
Chairs M.F. Rousseau (Brussels, Belgium)
P.L. Selvais (Hornu and Brussels, Belgium)		  
9.30 – 9.55 N-terminal pro-Atrial Natriuretic Factor and the biochemical assessment of congestive heart failure
P.L. Selvais (Hornu and Brussels, Belgium)		  
9.55 – 10.10 Development and validation of a new radio-immunoassay for the C-terminal fraction of the endothelin-1 precursor. Interest in heart failure population
R. Van Beneden, Ph. Selvais, Fr. Van Linden, S. Ahn, J.M. Ketelslegers, and M.F. Rousseau (Brussels, Belgium)
134
10.10 – 10.35 Is Insulin resistance a cardiac risk factor? 
M. Hermans (Brussels, Belgium)		  
10.35 – 10.45 discussion, end of session I  
10.45 – 11.15 coffee break  

Session II

    
Chairs M. Hermans (Brussels, Belgium)P.L. Selvais (Hornu and Brussels, Belgium)  
11.15 – 11.30 Influence of glycemic control on left ventricular diastolic function in type 1 diabetic patients: a 6-month follow-up study
A.M. Grandi, E. Piantanida, M. Bernasconi, I. Franzetti, F. Piperno, P. Marnini, L. Guasti, and A. Venco (Varese, Italy)
135
11.30 – 11.45 The roles of white blood count, fibrinogen, and CRP in diabetic coronary atherosclerosis
C. Saely, S. Aczel, T. Marte, P. Langer, and H. Drexel (Feldkirch, Austria)
136
11.45 – 12.00 Low apolipoprotein(A) in coronary patients with diabetes mellitus
C. Saely, S. Aczel, P. Langer, T. Marte, and H. Drexel (Feldkirch, Austria)
137
12.00 – 12.15 Leptin in men and women with coronary artery disease
L. Siemińska, C. Wojciechowska, E. Świętochowska E., E. Kozielska-Nowalany, J. Wodniecki, B. Kos-Kudła, B. Marek, D. Kajdaniuk, M. Nowak, and J. Głogowska-Szeląg (Zabrze, Poland)
138
12.15 – 12.30 discussion  
12.30 end of workshop 14  
     

Workshop 14   Posters 
Abstract no
Long term prognosis in congestive heart failure using cardiac neurohormones  
P.L. Selvais, S. Ahn, A. Robert, F. van Linden, J.-M. Ketelslegers, and M.F. Rousseau (Brussels, Belgium)
139
Past practice of sports and type 2 diabetes in later life
M.P. Hermans (Brussels, Belgium)
140
Plasma homocysteine and hormone replacement therapy in post-menopausal subjects with type 2 diabetes
M.P. Hermans, and M. Buysschaert (Brussels, Belgium)
141